Episode

The Future of Colorectal Cancer Screening: Reaching the Unscreened

Podcast
Becker’s Healthcare Podcast
Published
Sep 10, 2026
Duration seconds
1366
Processing state
not_requested
Canonical source
https://podcast.show/beckershealthcarepodcast/episode/155338738/
Audio
https://media.blubrry.com/beckershealthcarepodcast/ins.blubrry.com/beckershealthcarepodcast/BKR_HC_Guardant_Health_P_P_9-9-26_RD2.mp3
JSON
/v1/public/podcasts/becker-s-healthcare-podcast-484089/episodes/the-future-of-colorectal-cancer-screening-reaching-the-unscreened
Markdown
/podcast/becker-s-healthcare-podcast-484089/the-future-of-colorectal-cancer-screening-reaching-the-unscreened.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/becker-s-healthcare-podcast-484089/episodes/the-future-of-colorectal-cancer-screening-reaching-the-unscreened/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/becker-s-healthcare-podcast-484089/the-future-of-colorectal-cancer-screening-reaching-the-unscreened.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, Dr. AmirAli Talasaz, Co-Founder and Co-CEO of Guardant Health, discusses how blood-based screening can help close persistent colorectal cancer screening gaps and reach millions of unscreened patients. He also explores how the Shield Blood Test can increase screening participation, reconnect unscreened patients with health systems and enable earlier detection of colorectal cancer, particularly in rural and underserved communities. This episode is sponsored by Guardant Health .